🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Metastatic Pancreatic Adenocarcinoma
Clinical trial register · United States · industry-sponsored

Metastatic Pancreatic Adenocarcinoma Trials in the USA

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9109 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 19 Sep 2026, 04:27 UTC
9109
Studies in scope
industry-sponsored, all four open statuses
4946
Recruiting now
open to new participants
2196
Lead sponsors
across recruiting studies
Top states
California 4 Florida 3 Georgia 3 Kentucky 3 Arizona 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Astellas Pharma Global Development, Inc.3 Vaccinex Inc.1 Eleison Pharmaceuticals LLC.1 CG Pharmaceuticals, Inc1
State
California4 Florida3 Georgia3 Kentucky3 Arizona2
All 15 states
Target enrolment
to
6 of 9109 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
NCT07409272Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
614
Arizona, Arkansas, California, Connecticut, Florida, Georgia, Indiana, Kentucky
2026-02-17
Active, closed
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer
NCT06396091Metastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 1
12
Washington
2025-09-24
Active, closed
Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma
NCT05102721Metastatic Pancreatic Adenocarcinoma
Vaccinex Inc.
Phase 1/2
48
New York
2022-12-10
Active, closed
A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma
NCT05249101Metastatic Pancreatic Adenocarcinoma
CG Pharmaceuticals, Inc
Phase 1/2
70
Arizona, California, Georgia, Indiana, Kentucky, Louisiana, Michigan, New York
2022-08-15
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 2
393
California, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Missouri
2019-03-15
Recruiting
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
NCT01954992Metastatic Pancreatic Adenocarcinoma
Eleison Pharmaceuticals LLC.
Phase 3
480
California, Florida, Ohio
2014-04
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 September 2026. https://priyalifescience.com/clinical-trials-usa/condition/metastatic-pancreatic-adenocarcinoma

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.